These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4408136)

  • 21. [Multicentric clinical proof of a new oral antidiabetic glisoxepide (BS 4231). 3. Results of tolerance tests].
    Kiesselbach NH; Blumenbach L; Lehnert J
    Arzneimittelforschung; 1974 Mar; 24(0):447-52. PubMed ID: 4603694
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of high-carbohydrate diets on lipid and carbohydrate metabolism in the rat.
    Eaton RP; Kipnis DM
    Am J Physiol; 1969 Oct; 217(4):1160-8. PubMed ID: 5824318
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hypoglycemic action of certain heterocyclic carboxylic acid derivatives].
    Takasaki K; Kaneko M; Fujii T; Kobayashi H
    Nihon Yakurigaku Zasshi; 1973 Nov; 69(6):977-94. PubMed ID: 4799525
    [No Abstract]   [Full Text] [Related]  

  • 24. Circadian variations of carbohydrate tolerance in maturity onset diabetics treated with sulfonylureas.
    Göschke H; Denes A; Girard J; Collard F; Berger W
    Horm Metab Res; 1974 Sep; 6(5):386-91. PubMed ID: 4417576
    [No Abstract]   [Full Text] [Related]  

  • 25. Influence of an -amylase inhibitor (BAY d 7791) on blood glucose, serum insulin and NEFA in starch loading tests in rats, dogs and man.
    Puls W; Keup U
    Diabetologia; 1973 Apr; 9(2):97-101. PubMed ID: 4716119
    [No Abstract]   [Full Text] [Related]  

  • 26. Hypoglycaemic and related activities of a new pyrazolopyridine derivative (SQ 65,993).
    Polacek I; Schulze E; Burg H; Ouart J
    Arzneimittelforschung; 1974 Sep; 24(9):1242-7. PubMed ID: 4479785
    [No Abstract]   [Full Text] [Related]  

  • 27. [Study of the protective activity of glisolamide on experimental atherosclerosis in the rabbit].
    Dalla Vedova R; Cadel S; D'Alò G
    G Clin Med; 1979 Nov; 60(11):911-26. PubMed ID: 546672
    [No Abstract]   [Full Text] [Related]  

  • 28. The pharmacology of a new hypoglycaemic agent N-[4-(2-(2,3-dihydrobenzo (b) furan-7-carboxamido)-ethyl)-benzenesulphonyl]-N'-cyclohexylurea (NOVO CS 476). II. Pharmacological studies on the mechanism of action.
    Jorgensen KD
    Acta Pharmacol Toxicol (Copenh); 1977 Feb; 40(2):227-33. PubMed ID: 190857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Renal insufficiency and carbohydrates and lipids].
    Kobayashi F; Okamoto T; Koitabashi T; Ota T; Isoda K
    Nihon Rinsho; 1974 Mar; 32(3):505-17. PubMed ID: 4603796
    [No Abstract]   [Full Text] [Related]  

  • 30. [Multicentric clinical proof of a new oral antidiabetic glisoxepide (BS 4231). II. Proof of activity in the management of adult onset diabetes].
    Blumenbach L; Kiesselbach NH; Lehnert J
    Arzneimittelforschung; 1974 Mar; 24(0):437-46. PubMed ID: 4603692
    [No Abstract]   [Full Text] [Related]  

  • 31. [Mechanism of action of insulin on liver function].
    Genes SG
    Fiziol Zh; 1976; 22(6):830-9. PubMed ID: 797576
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacological study of a new hypoglycaemic sulphonamide: glisoxepid (RP 22410).
    Loubatières A; Mariani MM; Ribes G; Alric R; Agot H
    Diabetologia; 1972 Feb; 8(1):29-36. PubMed ID: 4554823
    [No Abstract]   [Full Text] [Related]  

  • 33. The time course of changes in carbohydrate and lipid metabolism in the rat as caused by starvation and refeeding.
    Nutr Rev; 1973 Jul; 31(7):222-3. PubMed ID: 4598158
    [No Abstract]   [Full Text] [Related]  

  • 34. The pharmacology and metabolism of oral antidiabetic drugs.
    Bänder A
    Aust N Z J Med; 1971 Aug; 1():Suppl 2:22-30. PubMed ID: 5005129
    [No Abstract]   [Full Text] [Related]  

  • 35. Rhaponticin from rhubarb rhizomes alleviates liver steatosis and improves blood glucose and lipid profiles in KK/Ay diabetic mice.
    Chen J; Ma M; Lu Y; Wang L; Wu C; Duan H
    Planta Med; 2009 Apr; 75(5):472-7. PubMed ID: 19235684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on the carbohydrate and lipid metabolism in thyroid disease: effects of glucagon.
    Levy LJ; Adesman JJ; Spergel G
    J Clin Endocrinol Metab; 1970 Mar; 30(3):372-9. PubMed ID: 5412544
    [No Abstract]   [Full Text] [Related]  

  • 37. [Multicentric clinical proof of a new oral antidiabetic glisoxepide (BS 4231). 1. Establishment of proof and methods].
    Lehnert J; Kiesselbach NH; Blumenbach L
    Arzneimittelforschung; 1974 Mar; 24(0):433-7. PubMed ID: 4603693
    [No Abstract]   [Full Text] [Related]  

  • 38. Glypentide: a new hypoglycaemic agent.
    Morell J
    Biochem Pharmacol; 1974 Oct; 23(20):2922-4. PubMed ID: 4429592
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of oral antidiabetic drugs on glycogen concentration and on glycogenolysis in different rat tissues.
    Kammerer L; Steingaszner O; Lévay J; Dénes R
    Rev Roum Med Intern; 1974; 11(1):145-7. PubMed ID: 4407682
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of repeated doses of phenyl-isopropyl-adenosine on lipid and carbohydrate metabolism in healthy fasting test subjects].
    Schaumann E; Schlierf G; Pfleiderer T; Weber E
    Arzneimittelforschung; 1972 Mar; 22(3):593-6. PubMed ID: 5067937
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.